Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
-

Safety

  • Share Share this page
-

Cozaar (losartan potassium) 25 mg, 50 mg, and 100 mg Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- June 2009

 

Summary View

 

ADVERSE REACTIONS

Post Marketing Experience
  • General Disorders and Administration Site Conditions: Malaise
    
-
-
-
-
-